New study results presented at the European Lung Cancer Congress (ELCC) 2025, March 26 to 29, demonstrate the role of AstraZeneca's TAGRISSO® (osimertinib), as monotherapy and as the backbone for ...

Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of n ...

(1) A non-GAAP financial measure or ratio which does not have a standardized meaning under the "Accounting Standards", see "Non-GAAP Measures" section of this press release. (2) A supplementary ...

State Key Laboratory of Chemical Resource Engineering, Department of Pharmaceutical Engineering, Beijing University of Chemical Technology, P.O. Box 53, 15 BeiSanHuan East Road, Beijing 100029, China ...

The driver and three others were inside the car when it collided with another vehicle just after crossing the Passaic River along Route 46, according to police. The prosecutor’s office has ...

DelveInsight's "TAGRISSO Market Size, Forecast, and Market Insight Report" highlights the details around TAGRISSO, a kinase inhibitor of the EGFR, which binds ...

The U.S. Air Force has recently paused deliveries of Boeing’s KC-46 Pegasus tanker aircraft and launched a fleet-wide inspection on the 89 aircraft currently in service. This decision came after ...

Department of Chemistry, Wertheim UF Scripps, Jupiter, Florida 33418, United States The Skaggs Graduate School of Chemical and Biological Sciences, 120 Scripps Way, Jupiter, Florida 33458, United ...

In LAURA Phase III trial, TAGRISSO continues to demonstrate improved overall survival trend in unresectable, Stage III setting SAVANNAH and ORCHARD Phase II trials show the addition of savolitinib ...

Purple Biotech Ltd. NT219 in combination with EGFR antibody cetuximab (Erbitux) is currently entering a Phase 2 study for head and neck cancer REHOVOT, Israel, March 05, 2025 (GLOBE NEWSWIRE ...